Source: Pharamceutical Technology

twoXAR: Ono and twoXAR form AI-based drug discovery alliance

Japan-based Ono Pharmaceutical has partnered with twoXAR, an artificial intelligence (AI)-driven biopharmaceutical firm, to discover and develop new treatments for...Read More...The post Ono and twoXAR form AI-based drug discovery alliance appeared first on Pharmaceutical Technology.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andrew A. Radin's photo - Co-Founder & CEO of twoXAR

Co-Founder & CEO

Andrew A. Radin

CEO Approval Rating

81/100

Read more